The abstract is read at the publisher; the summary is JClub's.
USP25 deficiency in mice mitigates age-related phenotypes by disrupting USP25’s direct deubiquitylation of SIRT1, enabling higher SIRT1 deacetylase activity and reduced senescence.
- Why it matters: SIRT1 controls cellular senescence, but how ubiquitin signaling regulates SIRT1 activity is not well defined, limiting therapeutic strategies for senescence-related diseases.
- What they did: The study mapped USP25–SIRT1 binding and showed USP25 mediates SIRT1 deubiquitylation of K63-linked polyubiquitination at lysines K506 and K513; it also created the cell-penetrating peptide pSirt1-4 to disrupt the interaction.
- The result: pSirt1-4 increases SIRT1 deacetylase activity and attenuates cellular senescence, supporting the USP25–SIRT1 axis as a therapeutic target for senescence-related conditions.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.